Al-Warhi, T.; Abualnaja, M.; Abu Ali, O.A.; Alyamani, N.M.; Elsaid, F.G.; Shati, A.A.; Albogami, S.; Fayad, E.; Abu Almaaty, A.H.; Mohamed, K.O.;
et al. Design, Synthesis and Cytotoxicity Screening of New Thiazole Derivatives as Potential Anticancer Agents through VEGFR-2 Inhibition. Symmetry 2022, 14, 1814.
https://doi.org/10.3390/sym14091814
AMA Style
Al-Warhi T, Abualnaja M, Abu Ali OA, Alyamani NM, Elsaid FG, Shati AA, Albogami S, Fayad E, Abu Almaaty AH, Mohamed KO,
et al. Design, Synthesis and Cytotoxicity Screening of New Thiazole Derivatives as Potential Anticancer Agents through VEGFR-2 Inhibition. Symmetry. 2022; 14(9):1814.
https://doi.org/10.3390/sym14091814
Chicago/Turabian Style
Al-Warhi, Tarfah, Matokah Abualnaja, Ola A. Abu Ali, Najiah M. Alyamani, Fahmy G. Elsaid, Ali A. Shati, Sarah Albogami, Eman Fayad, Ali H. Abu Almaaty, Khaled O. Mohamed,
and et al. 2022. "Design, Synthesis and Cytotoxicity Screening of New Thiazole Derivatives as Potential Anticancer Agents through VEGFR-2 Inhibition" Symmetry 14, no. 9: 1814.
https://doi.org/10.3390/sym14091814
APA Style
Al-Warhi, T., Abualnaja, M., Abu Ali, O. A., Alyamani, N. M., Elsaid, F. G., Shati, A. A., Albogami, S., Fayad, E., Abu Almaaty, A. H., Mohamed, K. O., Alamoudi, W. M., & Zaki, I.
(2022). Design, Synthesis and Cytotoxicity Screening of New Thiazole Derivatives as Potential Anticancer Agents through VEGFR-2 Inhibition. Symmetry, 14(9), 1814.
https://doi.org/10.3390/sym14091814
